Pe-565-01 programmed ventricular stimulation as an additional primary prevention risk stratification tool in arrhythmogenic right ventricular cardiomyopathy: a multinational study

A novel risk calculator predicting sustained ventricular arrhythmias (VA) in patients (pts) with arrhythmogenic right ventricular cardiomyopathy (ARVC) was recently proposed. It is unknown if programmed ventricular stimulation (PVS) provides additional prognostic value.